15:39 GMT12 August 2020
Listen Live
    Get short URL
    0 611

    Monsanto announced that the Broad Institute has granted a non-exclusive license for commercial use of its gene-splicing technology to the agricultural giant.

    WASHINGTON (Sputnik) — The Broad Institute, a joint project of Harvard University and The Massachusetts Institute of Technology, has granted a non-exclusive license for commercial use of its gene-splicing technology to the agricultural giant Monsanto, Monsanto announced in a press release on Thursday.

    "We are encouraged to see these tools being used to help deliver responsible solutions to help farmers meet the demands of our growing population," Monsanto said in the release.

    Monsanto and the Broad Institute share a number of patents used to develop an application known as CRISPER-Cas, which can be used to add, remove or combine genes in living organisms.

    "Genome-editing techniques present precise ways to dramatically improve the scale and discovery efficiency of new research that can improve human health and global agriculture," the release quoted Broad Institute Chief Business Officer Issi Rozen as saying.

    As the creator of genetically modified seeds widely used by farmers in the United States and elsewhere, Monsanto has become the target of environmental and other health-minded groups that are demanding that genetically modified food (GMO) be labeled.

    GMO products are illegal or severely restricted in much of Europe. In the United States, nearly all pre-packaged food is produced with some gene modified technology unless the products are clearly marked non-GMO.


    Whistleblowing Pays: Feds Dole Out Massive Award to Ex-Monsanto Exec
    Monsanto Cancels Plan to Launch Next Gen Cotton Seeds in India
    Senator: GMO Labeling Law in US Written 'By and For' Monsanto
    Monsanto Rejects Bayer Acquisition Proposal as Financially Inadequate
    license, commercial, genetic modification, GMO, genes, Monsanto, United States
    Community standardsDiscussion